Please Wait.....
Report
Global Cell and Gene Therapy Cold Chain Logistics Market Report and Forecast 2023-2031
Market Report I 2023-06-13 I 140 Pages I EMR Inc.
Global Cell and Gene Therapy Cold Chain Logistics Market Report and Forecast 2023-2031
Global Cell and Gene Therapy Cold Chain Logistics Market Outlook
The global cell and gene therapy cold chain logistics market was valued at USD 1.6 billion in 2022, driven by the increasing adoption of cell and gene therapies across the globe. The market size is anticipated to grow at a CAGR of 15.59% during the forecast period of 2023-2031 to achieve a value of USD 6 billion by 2031.
Cell and Gene Therapy Cold Chain Logistics: Introduction
Cell and gene therapies have revolutionized the field of medicine by offering innovative treatment options for various diseases and conditions. These therapies involve the use of living cells or genetic materials to target and treat specific disorders. However, the transportation and storage of these therapies' present unique challenges due to their sensitive nature and requirement for strict temperature control. This is where cell and gene therapy cold chain logistics come into play.
Cell and gene therapy cold chain logistics refer to the specialized processes and infrastructure required to maintain the integrity and efficacy of these therapies throughout their journey from manufacturing facilities to the patient's bedside. The primary goal is to ensure that the therapies remain within their required temperature range, typically cryogenic or ultra-low temperature conditions, to preserve their quality and effectiveness.
Key Trends in the Cell and Gene Therapy Cold Chain Logistics Market
Key trends in cell and gene therapy cold chain logistics include:
- Advancements in Temperature-Controlled Packaging: There is a continuous development of advanced packaging solutions, such as cryogenic shippers and insulated containers, that provide optimal temperature control during transportation. These packaging solutions are designed to minimize temperature fluctuations and maintain the required conditions for extended periods.
- Monitoring and Data Management: Real-time monitoring systems and data management platforms play a crucial role in ensuring the integrity of cell and gene therapies. These technologies enable continuous temperature monitoring, data logging, and alert systems to identify and mitigate any deviations or potential risks during transportation. This allows for proactive intervention and timely decision-making to maintain the therapy's quality.
- Regulatory Compliance: The regulatory landscape surrounding cell and gene therapies is evolving, and compliance with regulations and guidelines is of utmost importance. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have specific requirements for cold chain logistics, including documentation, validation, and quality management. Key trends focus on meeting these regulatory standards and adopting best practices to ensure compliance and patient safety.
Cell and Gene Therapy Cold Chain Logistics Market Segmentations
Market Breakup by Component
- Cryogenic Shippers
- Cryogenic Storage Freezers
- Ultra Low Freezers
- Cold Chain Management Systems
- Shipment and Storage Medium
- Cryogenic Packout Kits
- Others
Market Breakup by Services Offered
- Transportation
- Storage
- Packaging
Market by Mode of Transportation
- Air
- Ground
- Water
Market Breakup by Holding Temperature Range
- Cryogenic
- Refrigerated
- Ambient
- Others
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Cell and Gene Therapy Cold Chain Logistics Market Scenario
The market for cell and gene therapy cold chain logistics is experiencing significant growth and is expected to expand further in the coming years. The increasing adoption of cell and gene therapies as well as advancements in biotechnology and regenerative medicine are driving the demand for robust and efficient cold chain logistics solutions.
The market is characterized by the presence of several players offering specialized services in cell and gene therapy cold chain logistics. These players include logistics and transportation companies, packaging manufacturers, monitoring and data management solution providers, and cryopreservation technology developers. They collaborate with pharmaceutical and biotech companies, research institutions, and healthcare providers to ensure the safe and reliable transportation of cell and gene therapies.
In conclusion, the market for cell and gene therapy cold chain logistics is a vital component of the healthcare industry, enabling the safe and efficient delivery of innovative treatments. The market introduction involves the establishment of specialized facilities and the deployment of advanced technologies to meet the unique requirements of cell and gene therapies. With the increasing adoption of these therapies and advancements in the field, the market is expected to witness continuous growth and development.
Cell and Gene Therapy Cold Chain Logistics Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- BioLife Solutions, Inc.
- United Parcel Service (Marken)
- AmerisourceBergen Corporation (World Courier)
- Catalent, Inc.
- Atelerix Ltd.
- Cryoport, Inc.
- Biostor Ltd.
- Thermo Fisher Scientific Inc.
- Life Science Group Ltd (LSG)
- Yourway Biopharma Services Company
- Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions)
- Be The Match BioTherapies
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cell and Gene Therapy Cold Chain Logistics Market Overview
3.1 Global Cell and Gene Therapy Cold Chain Logistics Market Historical Value (2016-2022)
3.2 Global Cell and Gene Therapy Cold Chain Logistics Market Forecast Value (2023-2031)
4 Global Cell and Gene Therapy Cold Chain Logistics Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter's Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Cell and Gene Therapy Cold Chain Logistics Market Segmentation
5.1 Global Cell and Gene Therapy Cold Chain Logistics Market by Component
5.1.1 Market Overview
5.1.2 Cryogenic Shippers
5.1.3 Cryogenic Storage Freezers
5.1.4 Ultra Low Freezers
5.1.5 Cold Chain Management Systems
5.1.6 Shipment and Storage Medium
5.1.7 Cryogenic Packout Kits
5.1.8 Others
5.2 Global Cell and Gene Therapy Cold Chain Logistics Market by Services Offered
5.2.1 Market Overview
5.2.2 Transportation
5.2.3 Storage
5.2.4 Packaging
5.3 Global Cell and Gene Therapy Cold Chain Logistics Market by Mode of Transportation
5.3.1 Market Overview
5.3.2 Air
5.3.3 Ground
5.3.4 Water
5.4 Global Cell and Gene Therapy Cold Chain Logistics Market by Holding Temperature Range
5.4.1 Market Overview
5.4.2 Cryogenic
5.4.3 Refrigerated
5.4.4 Ambient
5.4.5 Others
5.5 Global Cell and Gene Therapy Cold Chain Logistics Market by End User
5.5.1 Market Overview
5.5.2 Pharmaceutical and Biotechnology Companies
5.5.3 Academic and Research Institutes
5.5.4 Others
5.6 Global Cell and Gene Therapy Cold Chain Logistics Market by Region
5.6.1 Market Overview
5.6.2 North America
5.6.3 Europe
5.6.4 Asia Pacific
5.6.5 Latin America
5.6.6 Middle East and Africa
6 North America Cell and Gene Therapy Cold Chain Logistics Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Cell and Gene Therapy Cold Chain Logistics Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Cell and Gene Therapy Cold Chain Logistics Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Cell and Gene Therapy Cold Chain Logistics Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Cell and Gene Therapy Cold Chain Logistics Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 BioLife Solutions, Inc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 United Parcel Service (Marken)
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 AmerisourceBergen Corporation (World Courier)
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Catalent, Inc.
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Atelerix Ltd.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Cryoport, Inc.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Biostor Ltd.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Thermo Fisher Scientific Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Life Science Group Ltd (LSG)
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Yourway Biopharma Services Company
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions)
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 Be The Match BioTherapies
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
17 Global Cell and Gene Therapy Cold Chain Logistics Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security